Literature DB >> 3886996

Possible involvement of terminal complement complex in active Heymann nephritis.

E de Heer, M R Daha, S Bhakdi, H Bazin, L A van Es.   

Abstract

We investigated whether the appearance of various complement components in renal deposits of immune complexes correlated with the development of proteinuria in rats with active Heymann nephritis. Sequential kidney biopsy specimens and serum samples were obtained from Lewis rats immunized with Fx1A in complete Freund's adjuvant. Circulating antibodies against purified auto-antigen renal tubular epithelial glycoprotein, as measured by ELISA, were found in the circulation together with a diffuse granular deposition of IgG1, IgG2a, and IgG2b in the glomeruli within 2 weeks after immunization. Biopsy specimens taken 4 weeks after immunization showed diffuse deposition of C4 and C3, which indicated that activation of complement by the classical pathway had occurred. The detection of the C5b-9 complex of complement in glomerular deposits coincided with the development of abnormal proteinuria indicating that the glomerular damage in this autoimmune disease may be caused by complement-mediated lesions in the glomerular capillary walls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886996     DOI: 10.1038/ki.1985.21

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.

Authors:  R J Specht Grijp-Glandorf; E De Heer; C C Dekker-Nooren; M R Daha; L A Van Es
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 2.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

3.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

Authors:  J Bariety; N Hinglais; S Bhakdi; C Mandet; M Rouchon; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen.

Authors:  A K Singh; M M Schwartz
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

5.  Transplacental induction of membranous nephropathy in a neonate.

Authors:  J Nauta; E de Heer; W M Baldwin; F J ten Kate; A J v d Heijden; E D Wolff
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

6.  Specific increases in urinary excretion of anti-DNA antibodies in lupus mice induced by lysozyme administration: further evidence for DNA-anti-DNA immune complexes in the pathogenesis of nephritis.

Authors:  T Yamamoto; M Nagase; A Hishida; N Honda
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

7.  Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.

Authors:  E De Heer; J A Bruijn; P J Hoedemaeker
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

8.  Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.

Authors:  E H Van Leer; P Ronco; P Verroust; A M van der Wal; P J Hoedemaeker; E De Heer
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

9.  Cyclosporin A induces long-term unresponsiveness in mercuric chloride-induced autoimmune glomerulonephritis.

Authors:  J Aten; C B Bosman; E De Heer; P J Hoedemaeker; J J Weening
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

10.  Nature of the glomerular capillary injury in human membranous glomerulopathy.

Authors:  O Shemesh; J C Ross; W M Deen; G W Grant; B D Myers
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.